Popular Articles
Burdock Root

Cook Medical Announces FDA Clearance For Advance(R) 35LP PTA Balloon Dilatation Catheter
Cook Medical has received clearance from the U.S. Food and Drug Administration (FDA) to market its newest balloon dilatation catheter, the Advance® 35LP. The device is intended for use in patients with lesions in the femoral, iliac and renal arteries and rounds out Cook"s complete line of low-profile PTA balloons.
generic viagra online
Advance In Detecting Melamine-adulterated Food
Researchers in Indiana are reporting an advance toward faster, more sensitive tests for detecting melamine, the substance that killed at least 6 children and sickened 300,000 children in China who drank milk and infant formula adulterated with the substance. The improved tests may ease global concerns about food safety, the researchers say. Their report is scheduled for the May 27 issue of ACS" Journal of Agricultural and Food Chemistry, a bi-weekly publication.
News of the day
California Immunization Coalition Honors Steve Baranov
The California Immunization Coalition recently bestowed the Natalie J. Smith, MD, MPH Immunization Champion Award upon Steve Baranov, vice president for community health at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center (LA BioMed) and executive director of South Los Angeles Health Projects.
Mental Health

The Leukemia & Lymphoma Society Calls For Blood Cancer Research Program At The Department Of Defense

George Dahlman, senior vice president of public policy for The Leukemia & Lymphoma Society (LLS), testified today before the U.S. Senate Subcommittee on Defense Appropriations, calling for funding for a dedicated, stand-alone blood cancer research program at the Department of Defense (DoD). The Institute of Medicine (IOM) has determined that several blood cancers, including chronic lymphocytic leukemia (CLL), lymphoma and multiple myeloma, are associated with exposure to chemical and biological agents from the Vietnam and two Gulf Wars. IOM has identified the need to begin a special research program that is responsive to the needs of military personal and veterans. LLS specifically called for the funding of a collaborative public-private effort between the U.S. Military Cancer Institute, LLS and a blue ribbon panel of scientific academicians. The USMCI has over 9 million electronic medical records detailing the health histories of service men and women and their families. The military also has serum and tissue specimens from these individuals stored as a routine step in their health care. These records and samples, together, provide a unique base that can power blood cancer research relevant to the military environment and lifestyle in a way that is not possible for any other population. "A joint effort, tapping the expertise of both USMCI and LLS, represents a unique opportunity to identify valuable research opportunities and state-of-the-art technology that can address significant questions on the origins and diagnosis of blood cancers," according to Dahlman. "DoD research on blood cancers addresses the importance of preparing for civilian and military exposure to the weapons being developed by several hostile nations and to aid in the march to more effective treatment for all who suffer from these diseases," Dahlman said. "This request clearly has merit for inclusion in the fiscal 2010 legislation." The Department of Defense already hosts research programs for breast and prostate cancers and, from 2001-2007, hosted a chronic myelogenous leukemia (CML) research program funded at $30 million over the six year period. About The Leukemia & Lymphoma Society The Leukemia & Lymphoma Society (R) (LLS) is the world"s largest voluntary health agency dedicated to blood cancer. The LLS mission: Cure leukemia, lymphoma, Hodgkin"s disease and myeloma, and improve the quality of life of patients and their families. LLS funds lifesaving blood cancer research around the world and provides free information and support services. The Leukemia & Lymphoma Society


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):